Article
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
Journal of virology - 1 Feb 2005
Gripon Philippe, Cannie Isabelle, Urban Stephan
Abstract excerpt
The lack of an appropriate in vitro infection system for the major human pathogen hepatitis B virus (HBV) has prevented a molecular understanding of the early infection events of HBV. We used the novel HBV-infectible cell line HepaRG and primary human hepatocytes to investigate the interference of infection by HBV envelope protein-derived peptides. We found that a peptide consisting of the authentically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
